natural-looking, long-lasting results. BELOTERO® recently marked 20 successful years in the aesthetics market, with over 18 million syringes sold worldwide, a true testament to its legacy.3 Smart Design. Precise Control. “From a design perspective,...
will be listed on Korea Exchange (KRX) on November 24, 2025, after establishment of a new subsidiary company on November 14, 2025. Samsung Bioepis will continue to operate its biosimilar business as a 100% owned subsidiary of Samsung Epis Holdings....
leadership and expertise in biosimilars.” BYOOVIZ (ranibizumab) was approved by the European Commission (EC) in August 2021 as the first ophthalmology biosimilar in Europe for the treatment of patients with Neovascular (Wet) Age-Related Macular...
medicines and medical technologies, announced that the U.S. Food and Drug Administration (FDA) designated Conexxence®(1) and Bomyntra®(2) (denosumab-bnht) as interchangeable biosimilars to the reference products, Prolia®(3) (denosumab) and...
with SVAX during the Future Investment Initiative (FII) week in Riyadh. This collaboration will focus on advancing RLS-1946, Rubedo’s promising lead candidate, through Phase 2 clinical trials in the Kingdom of Saud Arabia and the Emirate of Dubai....
the average operator scatter radiation dose during coronary and PCI procedures using the EggNest Complete System was only 0.16 mRem per case. For context, the annual occupational exposure limit in the U.S. is 5,000 mRem—meaning an operator would...
These products address indications within the diverse fields of tissue repair, aesthetics, and organ manufacturing. In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with...
with clear cell renal cell carcinoma (RCC) following nephrectomy. In this study, KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with WELIREG® (belzutifan), Merck’s first-in-class, oral hypoxia-inducible factor-2 alpha (HIF-2α)...
next-generation immunotherapies, announced that its manuscript describing the discovery and preclinical development of HCB101, an engineered SIRPα-Fc fusion protein, has been published in the Journal of Hematology & Oncology (SCI Impact Factor...
IFA Celtics, a leading Mexican pharmaceutical manufacturer, has partnered with ForgeStop Technology Corp, a U.S. connected product technology company, to launch NFC-enabled smart packaging that allows instant verification of medicines by...
Alcami Corporation a leading U.S.-based contract development and manufacturing organization (CDMO), is pleased to announce the expansion of its laboratory services at the Creekstone Drive facility in Durham, NC. This strategic investment...
be eligible to enroll in a long-term-open-label extension study. Enrollment for this Phase 3 program follows positive Phase 1/2 data demonstrating that ADX-324 achieved significant and durable suppression of prekallikrein (PKK) protein levels with...
by Lee Cronin to digitalize chemistry at global scale for the benefit of humanity. About Wing Venture Capital Founded in 2013, Wing works with ambitious founders to enable the AI-first transformation of business. We invest early, before it’s...
SurgiBox Inc. announced the successful deployment of its SurgiField System in Myanmar (Burma), where frontline medical teams used the portable surgical technology to perform life-saving procedures in active conflict zones. In a breakthrough...
These products address indications within the diverse fields of tissue repair, aesthetics, and organ manufacturing. In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with...
already use." For the pilot project, GeneDx used its fleet of NovaSeq X Plus Systems with constellation kits to evaluate 160 DNA samples from individuals with known genetic disease. GeneDx compared samples run with constellation to orthogonal...
hiPSCs. The CTIBIOTECH™ teams were selected by SATT AxLR for their unique expertise in 3D bioprinting, the fruit of over 15 years of R&D in human tissue biomanufacturing to facilitate the translation and industrial production of this technology at...
powering precision proteomics to enable the earliest detection of disease, announced the launch of the NULISAqpcr™ BD-pTau217 Assay— a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal...
fivefold increase in net sales and a sevenfold rise in operating income since the company joined the Asahi Kasei Group in 2012. In its medium-term management plan, Asahi Kasei has indicated it will capitalize on this steady growth by introducing...
Ltd. About Shanchol® Shanchol® is a bivalent killed whole-cell oral cholera vaccine, effective against Vibrio cholerae O1 and O139. It has been a cornerstone of UNICEF-coordinated outbreak responses and preventive immunization campaigns, protecting...